FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

17505211000001102: FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60578101000001110 FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60578201000001115 FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch Is a Estradiol 50micrograms/24hours patches 2 patch true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch Has AMP FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch Has specific active ingredient Estradiol true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Mawdsley-Brooks & Company Ltd) 2 patch VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start